Variable | Value | TB treatment outcome | Total | OR | AOR | 95 % CI | P value | |
---|---|---|---|---|---|---|---|---|
No success | Success | |||||||
Age | 15–24 | 9 (6.0 %) | 142 (94.0 %) | 151 | 0.243 | 0.150 | 0.041–0.546 | 0.004 |
25–34 | 15 (8.2 %) | 169 (91.8 %) | 184 | 0.34 | 0.185 | 0.055–0.619 | 0.006 | |
35–49 | 10 (6.6 %) | 141 (93.4 %) | 151 | 0.272 | 0.126 | 0.034–0.468 | 0.002 | |
50–64 | 9 (15 %) | 51 (85 %) | 60 | 0.676 | 0.389 | 0.104–1.457 | 0.161 | |
65–90 | 6 (20.7 %) | 23 (79.3 %) | 29 | |||||
TB classification | EP | 17 (6.7 %) | 236 (93.3 %) | 253 | 0.436 | 0.322 | 0.149–0.697 | 0.004 |
P/neg | 12 (6.7 %) | 168 (93.3 %) | 180 | 0.432 | 0.329 | 0.146–0.744 | 0.008 | |
P/pos | 20 (14.2 %) | 121 (85.8 %) | 141 | |||||
HIV status | Negative | 23 (6.4 %) | 337 (93.6 %) | 360 | 0.508 | 0.367 | 0.178–0.757 | 0.007 |
Positive | 20 (11.8 %) | 149 (88.2 %) | 169 |